Regulatory
Kala Pharmaceuticals’ Eysuvis (loteprednol etabonate ophthalmic suspension) Receives US FDA’s
Shots: The approval is based on results from four clinical trials, including three P-III trials and one P-II trial, that demonstrated significant improvements in both the signs and symptoms of […]readmore